Integral Derivatives’s Celgene Corp CELG Stock Holding History

Integral Derivatives’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.67M	Sell	41,200 -8,900	-18%	-$854K	0.09%	62
2017 Q4	$5.23M	Sell	50,100 -37,500	-43%	-$4.23M	0.1%	113
2017 Q3	$12.8M	Sell	87,600 -10,500	-11%	-$1.43M	0.23%	44
2017 Q2	$12.7M	Sell	98,100 -21,700	-18%	-$2.66M	0.26%	42
2017 Q1	$14.9M	Buy	119,800 +76,800	+179%	+$9.19M	0.27%	39
2016 Q4	$4.98M	Buy	43,000 +13,900	+48%	+$1.55M	0.09%	144
2016 Q3	$3.04M	Buy	29,100 +9,800	+51%	+$1.06M	0.06%	185
2016 Q2	$1.9M	Sell	19,300 -9,800	-34%	-$1.01M	0.05%	252
2016 Q1	$2.91M	Sell	29,100 -3,700	-11%	-$381K	0.1%	154
2015 Q4	$3.93M	Sell	32,800 -5,900	-15%	-$683K	0.1%	164
2015 Q3	$4.19M	Buy	38,700 +11,900	+44%	+$1.48M	0.11%	142
2015 Q2	$3.1M	Sell	26,800 -57,200	-68%	-$6.54M	0.08%	211
2015 Q1	$9.68M	Sell	84,000 -32,600	-28%	-$3.9M	0.2%	54
2014 Q4	$13M	Sell	116,600 -5,500	-5%	-$580K	0.23%	60
2014 Q3	$11.6M	Buy	122,100 +25,100	+26%	+$2.27M	0.21%	72
2014 Q2	$8.33M	Buy	97,000 +20,800	+27%	+$1.58M	0.14%	106
2014 Q1	$5.32M	Buy	76,200 +40,200	+112%	+$3.18M	0.1%	173
2013 Q4	$3.04M	Buy	+36,000	New	+$2.85M	0.04%	361

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Integral Derivatives's CELG Position: Q1 2018 in Review

Integral Derivatives opened a new position in Celgene Corp (CELG) in Q1 2018: 14,233 shares worth $1.27M. The stake represents 0.03% of the portfolio and ranks #187 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in CELG as recently as Q3 2017.

Integral Derivatives first reported a position in CELG in Q1 2014 and has held it in 11 quarters since. The position peaked at $3.85M in Q2 2014. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Integral Derivatives held 14,233 shares of Celgene Corp worth $1.27M as of Q1 2018.
Celgene Corp was a new Integral Derivatives position in Q1 2018.
Celgene Corp made up 0.03% of Integral Derivatives's portfolio in Q1 2018, its #187 holding.
Integral Derivatives first reported a position in Celgene Corp in Q1 2014 and has held it in 11 quarters since.
Integral Derivatives's Celgene Corp position peaked at $3.85M in Q2 2014.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.